AnalyzeDirect Nedjar Dinne et al. Ano1 Antisense Therapy Improves Enamel Properties in Molars but not Amelogenesis in a Murine Model of Cystic Fibrosis Calcified Tissue International.
Publication Date
April 3, 2026
How Analyze was Used
“Quantitative analyses were conducted using Analyze 14.0, which calculated the enamel surface area, volume, and density based on the same segmentation threshold used in OsiriX®. A set of phantoms calibrated in mg of hydroxyapatite per cm3 was used to convert CT intensity in Hounsfield unit.”
Keywords
Cystic fibrosis, G542X mutation, Antisense oligonucleotide therapy, ANO1, Enamel mineralization, Ameloblast function
Author Affiliation(s)
Université Paris Cité, Paris, France
